SOX11 and Epithelial-Mesenchymal Transition in Metastatic Serous Ovarian Cancer.
Iason PsilopatisJule Ida SchaeferDimitrios ArsenakisDimitrios BolovisGeorgia LevidouPublished in: Biomedicines (2023)
The present work, for the first time, provides preliminary evidence of a possible implication of SOX11 overexpression in the promotion of EMT in metastatic serous ovarian cancer, thereby endorsing tumor metastasis.